These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20659059)

  • 61. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes.
    Marinelli-Casey P; Gonzales R; Hillhouse M; Ang A; Zweben J; Cohen J; Hora PF; Rawson RA;
    J Subst Abuse Treat; 2008 Mar; 34(2):242-8. PubMed ID: 17596903
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis.
    Srisurapanont M; Arunpongpaisal S; Wada K; Marsden J; Ali R; Kongsakon R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):959-64. PubMed ID: 21277930
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Methamphetamine intoxication and suicidal ideation/behavior in the emergency department.
    Bayazit H; Baronia R; Wakefield SM
    Curr Med Res Opin; 2024 May; 40(5):849-854. PubMed ID: 38511972
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of a peer network intervention trial among young methamphetamine users in Chiang Mai, Thailand.
    Sherman SG; Sutcliffe C; Srirojn B; Latkin CA; Aramratanna A; Celentano DD
    Soc Sci Med; 2009 Jan; 68(1):69-79. PubMed ID: 18986746
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk factors for methamphetamine use in youth: a systematic review.
    Russell K; Dryden DM; Liang Y; Friesen C; O'Gorman K; Durec T; Wild TC; Klassen TP
    BMC Pediatr; 2008 Oct; 8():48. PubMed ID: 18957076
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacological treatments for methamphetamine addiction: current status and future directions.
    Ballester J; Valentine G; Sofuoglu M
    Expert Rev Clin Pharmacol; 2017 Mar; 10(3):305-314. PubMed ID: 27927042
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gender difference in early initiation of methamphetamine use among current methamphetamine users in Muse, Northern Shan State, Myanmar.
    Saw YM; Saw TN; Yasuoka J; Chan N; Kham NPE; Khine W; Cho SM; Jimba M
    Harm Reduct J; 2017 May; 14(1):21. PubMed ID: 28482847
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Meth/amphetamine use and associated HIV: Implications for global policy and public health.
    Degenhardt L; Mathers B; Guarinieri M; Panda S; Phillips B; Strathdee SA; Tyndall M; Wiessing L; Wodak A; Howard J;
    Int J Drug Policy; 2010 Sep; 21(5):347-58. PubMed ID: 20117923
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Health-related quality of life trajectories of methamphetamine-dependent individuals as a function of treatment completion and continued care over a 1-year period.
    Gonzales R; Ang A; Marinelli-Casey P; Glik DC; Iguchi MY; Rawson RA;
    J Subst Abuse Treat; 2009 Dec; 37(4):353-61. PubMed ID: 19553066
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern.
    Alammehrjerdi Z; Ezard N; Dolan K
    Asian J Psychiatr; 2018 Jan; 31():49-55. PubMed ID: 29414387
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Commentary on Marshall et al. (2010): are long-term negative health consequences of methamphetamine use important to youth?
    Rawson RA; Gonzales R
    Addiction; 2010 Jun; 105(6):1003-4. PubMed ID: 20659060
    [No Abstract]   [Full Text] [Related]  

  • 72. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
    McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
    Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Risk of Cardiovascular Diseases and Stroke Events in Methamphetamine Users: A 10-Year Follow-Up Study.
    Huang MC; Yang SY; Lin SK; Chen KY; Chen YY; Kuo CJ; Hung YN
    J Clin Psychiatry; 2016 Oct; 77(10):1396-1403. PubMed ID: 27574836
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia.
    Degenhardt L; Roxburgh A; McKetin R
    Med J Aust; 2007 Apr; 186(7):342-5. PubMed ID: 17407429
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Performance of a quality assurance program for assessing dental health in methamphetamine users.
    Dye BA; Harrell L; Murphy DA; Belin T; Shetty V
    BMC Oral Health; 2015 Jul; 15():76. PubMed ID: 26143495
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Acute exercise ameliorates craving and inhibitory deficits in methamphetamine: An ERP study.
    Wang D; Zhou C; Chang YK
    Physiol Behav; 2015 Aug; 147():38-46. PubMed ID: 25846839
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The relationship between impulsivity and methamphetamine use severity in a community sample.
    Moallem NR; Courtney KE; Ray LA
    Drug Alcohol Depend; 2018 Jun; 187():1-7. PubMed ID: 29626740
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Criminal justice itreatment admissions for methamphetamine use in California: a focus on Proposition 36.
    Anglin MD; Urada D; Brecht ML; Hawken A; Rawson R; Longshore D
    J Psychoactive Drugs; 2007 Nov; Suppl 4():367-81. PubMed ID: 18284103
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pattern of Methamphetamine Use and the Time Lag to Methamphetamine Dependence.
    Yimsaard P; Maes MM; Verachai V; Kalayasiri R
    J Addict Med; 2018; 12(2):92-98. PubMed ID: 29176447
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Letter to the Editor-Is Chronic Methamphetamine-Induced Psychosis A Mental Disease for the Purposes of Insanity?
    Reisner AD; Piel JL
    J Forensic Sci; 2020 Jul; 65(4):1382-1383. PubMed ID: 32396213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.